← Back to Search

Procedure

Long-Term EEG Monitoring for Epilepsy (REMI Trial)

N/A

Recruiting

Research Sponsored by Epitel, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients have a reported history of seizures (epileptic, non-epileptic, or unknown)

The Patient (or Primary Caregiver) must be competent to follow all study procedures

Timeline

Screening 3 weeks

Treatment Varies

Follow Up twenty-eight (28) days

Awards & highlights

REMI Trial Summary

This trial tests a portable EEG device to record seizures over 14-28 days to help clinicians better understand and diagnose seizures.

Who is the study for?

This trial is for adults aged 18-70 with a history of seizures, who can consent to the study and follow procedures. They must be willing to wear an EEG device almost all day (20+ hours) for up to 30 days and have at least one seizure every two weeks. It's not suitable for those in other trials, allergic to certain medical materials, without stable housing or power supply.Check my eligibility

What is being tested?

The REMI™ system by Epitel is being tested to see if it can capture more seizure events over a longer period (14-28 days) compared to traditional methods. The study will evaluate whether extended EEG monitoring provides valuable information for clinicians treating epilepsy.See study design

What are the potential side effects?

There may be discomfort or skin irritation from wearing the EEG device continuously due to sensitivity towards medical acrylics, silicones, or hydrogels used in the device.

REMI Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have a history of seizures.

Select...

I (or my caregiver) can follow all the study's instructions.

Select...

I am between 18 and 70 years old.

Select...

I experience at least one seizure every two weeks.

REMI Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ twenty-eight (28) days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~twenty-eight (28) days

This trial's timeline: 3 weeks for screening, Varies for treatment, and twenty-eight (28) days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Ictal Events Identified in fourteen (14) days.

Secondary outcome measures

Extended Use

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

Epitel, Inc.Lead Sponsor

3 Previous Clinical Trials

923 Total Patients Enrolled

2 Trials studying Epilepsy

879 Patients Enrolled for Epilepsy

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are geriatric individuals being accepted as participants in this research initiative?

"These clinical trial requirements stipulate that the minimum age is 18 and the maximum age is 70. Moreover, there are 129 trials specifically designed for minors and 206 studies meant to aid individuals over 65 years of age."

Answered by AI

Are there currently opportunities to take part in this experimental research?

"Clinicaltrials.gov states that this medical study, which began recruitment on September 15th 2023 and concluded its search for participants on August 31st 2022, is no longer searching for candidates. However, there are 314 other clinical trials actively accepting patients at the current time."

Answered by AI

Who meets the criteria to partake in this investigation?

"The trial is looking for 65 individuals, aged between 18 and 70, who are currently diagnosed with epilepsy. In addition to the base requirements, participants must have undergone ambulatory EEG scans as part of their medical care, report a history of seizures (epileptic or non-epileptic) in the past two weeks, and experience at least one seizure every fortnightly period."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.

2023. "Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06027749.

All > Epilepsy